Skip to main content

Optimizing Tissue Preparation for Molecular Testing in Thyroid Tumors: A Retrospective Analysis of 177 Cases from a High-Volume Japanese Center.

Hirokawa M, Higuchi M, Akamizu T, Kihara M, Suzuki A

Publication: Cancers (2026) • Vol 18PMID: 42794941View on PubMed

Purpose

This paper compared the success rates of the Oncomine Dx and/or BRAF3 assays were evaluated in formalin-fixed, paraffin-embedded (FFPE) thyroid carcinoma specimens that were fixed in either unbuffered formalin and stored for 2-27 years or in neutral buffered formalin and stored for 0-6 years.

Conclusion

The majority of FFPE blocks analyzed using each assay were stored for ≤6 years before testing (84.7% for Oncomine Dx and 70.9% for BRAF3). BRAF3 DNA analysis was successful in all 79 specimens, including the 33 specimens fixed in unbuffered formalin and the 21 stored for 8-27 years. In contrast, the Oncomine Dx DNA analysis was successful in 94 of 98 specimens, including all 35 specimens analyzed using both assays. All four specimens that failed in the Oncomine Dx DNA analysis were fixed in unbuffered formalin (3 specimens were fixed for 48 h and one was fixed for 72 h).  Oncomine Dx DNA analysis was successful in all 13 specimens and in 11 of the 15 specimens fixed in unbuffered formalin and stored as FFPE blocks for <6 years and > 6 years, respectively. One specimen that failed (stored for 8-9 years) had an average length of regions with base quality ≥20 (AQ20) of 62, which was below the acceptable threshold of 70, and all 4 specimens that failed had a percentage of DNA reads below the threshold of ≥ 0.7 (range 0.51–5.58).  Oncomine Dx RNA analysis failed in a single specimen that was fixed in unbuffered formalin for 48 h and stored for 3-4 years. The authors report that this specimen had low RNA quality (details not provided).

Studies (1)

Purpose

This study compared the success rates of the Oncomine Dx and/or BRAF3 assays were evaluated in formalin-fixed, paraffin-embedded (FFPE) thyroid carcinoma specimens that were fixed in either unbuffered formalin and stored for 2-27 years or in neutral buffered formalin and stored for 0-6 years.  Thyroidectomy, lymph node or neck biopsy specimens were collected from 177 patients with thyroid carcinomas (138 papillary, 6 follicular, 3 medullary, 7 poorly differentiated and 23 anaplastic) and fixed in unbuffered formalin (the 61 specimens collected prior to April 2020) or 10% neutral buffered formalin (the 116 specimens collected during/after April 2020) within 1 h of resection. Surgical specimens were injected with formalin prior to immersion for 48-72 h. Biopsy specimens were fixed by immersion for 24 h. Specimens were paraffin-embedded (details not provided) and stored for up to 27 years (details not provided). Genetic testing was performed using Oncomine Dx (98 specimens) or BRAF3 (79 specimens) assays or both assays (35 specimens) by commercial laboratories.

Summary of Findings

The majority of FFPE blocks analyzed using each assay were stored for ≤6 years before testing (84.7% for Oncomine Dx and 70.9% for BRAF3). BRAF3 DNA analysis was successful in all 79 specimens, including the 33 specimens fixed in unbuffered formalin and the 21 stored for 8-27 years. In contrast, the Oncomine Dx DNA analysis was successful in 94 of 98 specimens, including all 35 specimens analyzed using both assays. All four specimens that failed in the Oncomine Dx DNA analysis were fixed in unbuffered formalin (3 specimens were fixed for 48 h and one was fixed for 72 h).  Oncomine Dx DNA analysis was successful in all 13 specimens and in 11 of the 15 specimens fixed in unbuffered formalin and stored as FFPE blocks for <6 years and > 6 years, respectively. One specimen that failed (stored for 8-9 years) had an average length of regions with base quality ≥20 (AQ20) of 62, which was below the acceptable threshold of 70, and all 4 specimens that failed had a percentage of DNA reads below the threshold of ≥ 0.7 (range 0.51–5.58).  Oncomine Dx RNA analysis failed in a single specimen that was fixed in unbuffered formalin for 48 h and stored for 3-4 years. The authors report that this specimen had low RNA quality (details not provided).

  • Biospecimens

    TissueThyroid Gland
    TissueLymph Node
    TissueHead and Neck
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    DNANext generation sequencing
    RNANext generation sequencing
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen PreservationType of fixation/preservation
    Formalin (buffered)
    Formalin (unbuffered)
    StorageStorage duration
    0-6 years
    2-27 years
    Next generation sequencing SpecificTechnology platform
    BRAF3
    Oncomine Dx